Literature DB >> 17197649

Adult attention-deficit hyperactivity disorder: recognition and treatment in general adult psychiatry.

Philip Asherson, Wai Chen, Bridget Craddock, Eric Taylor.   

Abstract

Attention-deficit hyperactivity disorder (ADHD) is a common disorder affecting children and adults. Many young people treated with stimulants, as well as those in whom ADHD went unrecognised in childhood, need treatment as adults. Stimulants and atomoxetine effectively reduce ADHD symptoms at all ages and should be a standard treatment in general adult psychiatric practice.

Entities:  

Mesh：

Year:  2007        PMID： 17197649     DOI： 10.1192/bjp.bp.106.026484

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN： 0007-1250            Impact factor:   9.319


  27 in total

1.  Whither the psychosis-neurosis borderline.

Authors:  Ian Kelleher; Mary Cannon
Journal:  Schizophr Bull       Date:  2014-01-16       Impact factor: 9.306

Review 2.  Dexmethylphenidate extended release: a review of its use in the treatment of attention-deficit hyperactivity disorder.

Authors:  Marit D Moen; Susan J Keam
Journal:  CNS Drugs       Date:  2009-12       Impact factor: 5.749

Review 3.  European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD.

Authors:  Sandra J J Kooij; Susanne Bejerot; Andrew Blackwell; Herve Caci; Miquel Casas-Brugué; Pieter J Carpentier; Dan Edvinsson; John Fayyad; Karin Foeken; Michael Fitzgerald; Veronique Gaillac; Ylva Ginsberg; Chantal Henry; Johanna Krause; Michael B Lensing; Iris Manor; Helmut Niederhofer; Carlos Nunes-Filipe; Martin D Ohlmeier; Pierre Oswald; Stefano Pallanti; Artemios Pehlivanidis; Josep A Ramos-Quiroga; Maria Rastam; Doris Ryffel-Rawak; Steven Stes; Philip Asherson
Journal:  BMC Psychiatry       Date:  2010-09-03       Impact factor: 3.630

Review 4.  Clinical recommendations in current practice guidelines for diagnosis and treatment of ADHD in adults.

Authors:  Christopher Gibbins; Margaret Weiss
Journal:  Curr Psychiatry Rep       Date:  2007-10       Impact factor: 5.285

Review 5.  Emotional Lability in Patients with Attention-Deficit/Hyperactivity Disorder: Impact of Pharmacotherapy.

Authors:  Ann C Childress; Floyd R Sallee
Journal:  CNS Drugs       Date:  2015-08       Impact factor: 5.749

6.  Management of adult attention deficit hyperactivity disorder in UK primary care: a survey of general practitioners.

Authors:  Suzanne McCarthy; Lynda Wilton; Macey Murray; Paul Hodgkins; Philip Asherson; Ian C K Wong
Journal:  Health Qual Life Outcomes       Date:  2013-02-22       Impact factor: 3.186

7.  Adult ADHD and comorbid depression: A consensus-derived diagnostic algorithm for ADHD.

Authors:  Diane McIntosh; Stan Kutcher; Carin Binder; Anthony Levitt; Angelo Fallu; Michael Rosenbluth
Journal:  Neuropsychiatr Dis Treat       Date:  2009-04-08       Impact factor: 2.570

8.  Safety and tolerability of flexible dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder.

Authors:  Jan K Buitelaar; J Antoni Ramos-Quiroga; Miguel Casas; J J Sandra Kooij; Asko Niemelä; Eric Konofal; Joachim Dejonckheere; Bradford H Challis; Rossella Medori
Journal:  Neuropsychiatr Dis Treat       Date:  2009-09-15       Impact factor: 2.570

9.  Electrophysiological evidence for abnormal preparatory states and inhibitory processing in adult ADHD.

Authors:  Gráinne McLoughlin; Bjoern Albrecht; Tobias Banaschewski; Aribert Rothenberger; Daniel Brandeis; Philip Asherson; Jonna Kuntsi
Journal:  Behav Brain Funct       Date:  2010-10-28       Impact factor: 3.759

10.  Are parental ADHD problems associated with a more severe clinical presentation and greater family adversity in children with ADHD?

Authors:  Sharifah Shameem Agha; Stanley Zammit; Anita Thapar; Kate Langley
Journal:  Eur Child Adolesc Psychiatry       Date:  2013-02-06       Impact factor: 4.785
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.